Growing community of inventors

Brisbane, CA, United States of America

Ryan Hudson

Average Co-Inventor Count = 2.29

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Ryan HudsonAnne-Marie Beausoleil (8 patents)Ryan HudsonF Anthony Romero (2 patents)Ryan HudsonRemi-Martin Laberge (2 patents)Ryan HudsonRyan Hudson (8 patents)Anne-Marie BeausoleilAnne-Marie Beausoleil (32 patents)F Anthony RomeroF Anthony Romero (39 patents)Remi-Martin LabergeRemi-Martin Laberge (24 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Unity Biotechnology, Inc. (8 from 41 patents)


8 patents:

1. 12221433 - Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer

2. 10981892 - Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer

3. 10745429 - Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer

4. 10738042 - Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer

5. 10717722 - Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer

6. 10703745 - Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer

7. 10689416 - Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer

8. 10519197 - Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…